.
MergerLinks Header Logo

New Deal


Cover Image LEYDEN LABS
LEYDEN LABS

LEYDEN LABS

Summary


Developer of preventive medicines designed to target respiratory viruses. The company's medicines target commonalities of virus families to protect against many viruses simultaneously as opposed to vaccines that typically protect against a specific virus variant, thereby providing people with the freedom to protect themselves from infection and prevent transmission.

Deals Overview

Total Deals2
Valued Deals2
Total Value£65M
Avg. Deal Size£32M

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US